Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
Dr. Breelyn Wilky
Advertisement
Dr. Breelyn Wilky is an associate professor of medicine in the Department of Medical Oncology at the University of Colorado, Anschutz Medical Campus. She also serves as the director of Sarcoma Medical Oncology, deputy associate director for Clinical Research, and the Cheryl Bennett and McNeilly Family Endowed Chair in Sarcoma Research at the University of Colorado Cancer Center, UCHealth.
Articles by Dr. Breelyn Wilky
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
B7-H3 CAR T-Cell Therapy Shows Acceptable Safety in Recurrent Glioblastoma
2
Voranigo Plus Temodar Found to Be Safe in Patients With IDH1/2+ Glioma
3
Giredestrant Shows Benefit for Early Breast Cancer in Phase 3 Trial
4
Early Real-World Uptake of Voranigo in Patients With IDH-Mutant Glioma
5
